Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Kumazaki

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Radiation Research|December 29, 2010
Multi-institutional retrospective analysis of the inhomogeneity correction for radiation therapy of lung cancerHideyuki Mizuno, Hiroyuki Okamoto, Miyoko Fukuoka, et al.
Clinical and Translational Radiation Oncology|June 13, 2020
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancerSatoshi Saito, Takanori Abe, Nao Kobayashi, et al.
Technical Innovations & Patient Support in Radiation Oncology|May 22, 2026
Mixed reality-guided intraoperative visual support for combined intracavitary and interstitial brachytherapy for cervical cancerRyuta Hirai, Tomohiro Ohta, Mitsunobu Igari, et al.
Thoracic Cancer|September 2, 2022
Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapyTakanori Abe, Misaki Iino, Satoshi Saito, et al.
Journal of Radiation Research|June 14, 2021
Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapySatoshi Saito, Takanori Abe, Misaki Iino, et al.
Journal of Radiation Research|December 6, 2020
Results of definitive radiotherapy with concurrent chemotherapy for maxillary sinus carcinomas with neck lymph node metastasisTakanori Abe, Satoshi Saito, Misaki Iino, et al.
Journal of Radiation Research|July 14, 2021
Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancerTakanori Abe, Misaki Iino, Satoshi Saito, et al.
Japanese Journal of Clinical Oncology|September 28, 2021
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancerTakanori Abe, Yasuhiro Ryuno, Misaki Iino, et al.
Thoracic Cancer|December 8, 2020
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy aloneTakanori Abe, Satoshi Saito, Misaki Iino, et al.
Radiation Oncology (London, England)|July 19, 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective studyYasuhiro Ryuno, Takanori Abe, Misaki Iino, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Radiation Research|December 29, 2010
Multi-institutional retrospective analysis of the inhomogeneity correction for radiation therapy of lung cancerHideyuki Mizuno, Hiroyuki Okamoto, Miyoko Fukuoka, et al.
Clinical and Translational Radiation Oncology|June 13, 2020
Incidence and dose-volume relationship of radiation pneumonitis after concurrent chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancerSatoshi Saito, Takanori Abe, Nao Kobayashi, et al.
Technical Innovations & Patient Support in Radiation Oncology|May 22, 2026
Mixed reality-guided intraoperative visual support for combined intracavitary and interstitial brachytherapy for cervical cancerRyuta Hirai, Tomohiro Ohta, Mitsunobu Igari, et al.
Thoracic Cancer|September 2, 2022
Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapyTakanori Abe, Misaki Iino, Satoshi Saito, et al.
Journal of Radiation Research|June 14, 2021
Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapySatoshi Saito, Takanori Abe, Misaki Iino, et al.
Journal of Radiation Research|December 6, 2020
Results of definitive radiotherapy with concurrent chemotherapy for maxillary sinus carcinomas with neck lymph node metastasisTakanori Abe, Satoshi Saito, Misaki Iino, et al.
Journal of Radiation Research|July 14, 2021
Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancerTakanori Abe, Misaki Iino, Satoshi Saito, et al.
Japanese Journal of Clinical Oncology|September 28, 2021
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancerTakanori Abe, Yasuhiro Ryuno, Misaki Iino, et al.
Thoracic Cancer|December 8, 2020
Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non-small cell lung cancer in comparison with chemoradiotherapy aloneTakanori Abe, Satoshi Saito, Misaki Iino, et al.
Radiation Oncology (London, England)|July 19, 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective studyYasuhiro Ryuno, Takanori Abe, Misaki Iino, et al.
Pageof 5